Learn More
EIPA, MedChemExpress
MedChemExpress EIPA (L593754) is an orally active TRPP3 channel inhibitor with an IC50 of 10.5 ÎĽM. EIPA also enhances autophagy by inhibiting Na+/H+-exchanger 3 (NHE3). EIPA inhibits macropinocytosis as well. EIPA can be used in the research of inflammation and cancers, such as gastric cancer, colon carcinoma, pancreatic carcinoma.
Brand: Medchem Express HY-101840

Description
EIPA (L593754) is an orally active TRPP3 channel inhibitor with an IC50 of 10.5 ÎĽM. EIPA also enhances autophagy by inhibiting Na+/H+-exchanger 3 (NHE3). EIPA inhibits macropinocytosis as well. EIPA can be used in the research of inflammation and cancers, such as gastric cancer, colon carcinoma, pancreatic carcinoma.Specifications
EIPA | |
Yellow | |
C11H18ClN7O | |
L593754 MH 12-43 | |
O=C(C1=NC(Cl)=C(N(CC)C(C)C)N=C1N)NC(N)=N | |
299.76 | |
Research | |
Cancer-programmed cell death |
1154-25-2 | |
Research | |
5 mg | |
DMSO : 140 mg/mL (467.04 mM; Need ultrasonic) | |
299.76 | |
98.0% | |
Solid |
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.
Research purposes only